Skip to content

Newmark Group, Inc. NMRK Short-term restricted investments

Short-term restricted investments at other companies

UroGen Pharma logo
UroGen PharmaURGN
$177K+0.6%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$884M+43.3%
UFP Industries, Inc. logo
UFP Industries, Inc.UFPI
$51.3M+22.0%
Ingevity logo
IngevityNGVT
$24.7M
Construction Partners logo
Construction PartnersROAD
$16.15M-20.1%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$70M+6.1%

Other financials

Income statement

See full
Revenue$846.5M+27.2%
Operating income$27.0M+254%
Net income$14.4M+264%
EPS (diluted)$0.08+260%

Balance sheet

See full
Cash & equivalents$219.6M-17.9%
Total debt$1.3B-3.0%
Total equity$1.4B+5.9%
Total assets$5.3B+8.9%

Cash flow

See full
Operating cash flow-$247.6M-38.0%
CapEx$10.2M+87.6%
Free cash flow-$257.8M-39.5%

Valuation

See full
Market cap$2.67B+25.9%
Enterprise value$3.78B+17.5%
P/E17.9×-4.9×
P/S0.8×0.0×

Profitability

See full
Operating margin8%+2.1pp
Net margin4.3%+1.0pp
FCF margin2%

Returns & leverage

See full
Return on equity11%+3.7pp
Debt / equity0.9×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Newmark Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsCurrent.

The official record: Newmark Group, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Newmark Group, Inc.'s short-term restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Newmark Group, Inc.'s short-term restricted investments?
Newmark Group, Inc. (NMRK) reported short-term restricted investments of $115.38M in Q1 2026.